|
|
Focusing on the research and development of generic and innovative drugs, Qilu Pharmaceutical has formed a complete innovative development system covering early stage discovery, development and commercialization of chemical and biologic drugs with five major R&D centers based in China and US as the innovation source. The research team, comprised of over 3,000 members, fully utilizes the innovative drug R & D center technology with global independent intellectual property right (IPR), targeting at the tumor and autoimmune diseases, the team has initiated over 60 new “First-in-Class” drug projects. |
Relying on strong scientific research and innovation capabilities, Qilu Pharmaceutical has launched more than 300 products on the market, among which 50+ were “First-to-Launch” in China, together with more than 200 products under the development pipeline. In the past one decade, Qilu Pharmaceutical has undertaken 41 major national science and technology projects targeted for the development of new drugs.
0531-83126666 
wangzhan@qilu-pharma.com 
Tel: +86-531-83127705, 83127704, 83127706, 83127711
Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China
Email：export@qilu-pharma.com
监督举报
亲爱的合作伙伴：
欢迎举报以下行为！
索贿、暗箱操纵招标、内定中标单位、员工或亲属参与公司业务往来牟取私利、偷工减料、以次充好、故意刁难供应商等行为。
举报电话：0531-83126898/55820713/83126871
举报邮箱：qljc@qilu-pharma.com
收信地址：山东省济南市历城区旅游路8888号
齐鲁制药集团审计监察部
采购平台技术专线